by Halia Therapeutics | Feb 9, 2023 | Press Releases
Halia is excited to announce that Anya Neidig, MSN, RN, has joined our clinical team as Director of Clinical Operations. Anya brings over 20 years of experience in patient care and will help advance our #NEK7 and #LRRK2 programs through multiple clinical trials in... by Halia Therapeutics | Aug 16, 2022 | Press Releases
SALT LAKE CITY (August 16, 2022) – Halia Therapeutics, the first biotechnology company to target NEK7 to block the assembly of the NLRP3 inflammasome complex, participated today in a fireside chat exploring approaches to innovate Alzheimer’s therapies at... by Halia Therapeutics | Aug 1, 2022 | Press Releases
SALT LAKE CITY (August 1, 2022) – Halia Therapeutics, a biotechnology company that has used a structure-based drug design strategy to discover a series of small molecule therapeutics targeting important mediators of inflammation, announced today that it will present a...